SGT-263

$190.00$6,500.00

SGT-263 is a new noid, which acts upon the noid receptors, and is a key component of many synthetic cannabis powders. SGT-263 is the latest noid on the research chemical scene. It was first identified by the EMCDDA in February 2015. SGT-263 or 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-7-azaindole-3-carboxamide is a pyrrolo[2,3-b]pyridine-3-carboxamide based synthetic cannabinoid that has been sold as a designer drug. Not for human consumption.
Clear
Category: